Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2012
10/11/2012WO2012137216A1 A novel pharmaceutical formulation of alpha ketoanalogue of amino acids and additional amino acids for treatment of chronic kidney disease and method of preparation thereof
10/11/2012WO2012137209A1 Synergistic compositions and methods
10/11/2012WO2012137181A1 Inhibitors of viral replication, their process of preparation and their therapeutical uses
10/11/2012WO2012137166A1 An oxoborolidine compound and uses thereof
10/11/2012WO2012137164A1 Antimicrobial compositions, antibiofilm compositions and uses thereof
10/11/2012WO2012137163A1 Flour-based functional food
10/11/2012WO2012137142A1 Novel salts of raltegravir
10/11/2012WO2012137111A1 Crystalline and non- crystalline forms of tofacitinib, and a pharmaceutical composition comprising tofacitinib and a penetration enhancer
10/11/2012WO2012137106A1 The treatment of viral infections
10/11/2012WO2012137099A1 Imidazole, pyrazole, and triazole derivatives useful as antibacterial agents
10/11/2012WO2012137094A1 Isoxazole derivatives useful as antibacterial agents
10/11/2012WO2012137089A1 Pyrrolo [2, 3 -d] pyrimidine derivatives as inhibitors of tropomyosin- related kinases
10/11/2012WO2012136997A1 G-quadruplex stabilising agent
10/11/2012WO2012136968A1 Composition comprising antimicrobial metal ions and a quaternary cationic surfactant
10/11/2012WO2012136937A1 Zinc n-acetyl taurinate for the treatment of prostate cancer
10/11/2012WO2012136910A1 Derivatives of 4-arylcoumarin and 4-arylquinoline, therapeutic uses thereof and method for synthesising same
10/11/2012WO2012136859A1 Medicament for liver regeneration and for treatment of liver failure
10/11/2012WO2012136852A1 Method for increasing the replication capacity of an influenza virus in cultured cells
10/11/2012WO2012136851A1 Methods and pharmaceutical compositions for inhibiting influenza viruses replication
10/11/2012WO2012136839A1 Dry formulation and pharmaceutical composition comprising fesoterodine or a salt or a solvate thereof
10/11/2012WO2012136838A1 Pharmaceutical composition comprising fesoterodine
10/11/2012WO2012136834A1 Pyrimidine derivatives for the treatment of viral infections
10/11/2012WO2012136829A1 Novel combination treatment of cancer
10/11/2012WO2012136816A2 Pharmaceutical composition
10/11/2012WO2012136806A1 Special fluid composition and use thereof
10/11/2012WO2012136776A1 Imidazopyridazines as akt kinase inhibitors
10/11/2012WO2012136772A1 Fused pyrrole derivates as estrogen receptor ligands
10/11/2012WO2012136761A1 Process for the preparation of a sulfated derivative of 3,5-diiodo-o-[3-iodophenyl]-l-tyrosine
10/11/2012WO2012136732A1 Treatment of multiple myeloma with masitinib
10/11/2012WO2012136724A1 Substituted pyrimidinium compounds for combating animal pests
10/11/2012WO2012136722A1 Hydroxyphenyl pyrrole compounds containing an hydroxamic acid as hdac inhibitors and medicinal applications thereof
10/11/2012WO2012136711A1 Anilide-alkyl thioethers as acat inhibitors for the treatment of dermatological diseases
10/11/2012WO2012136699A1 Use of l-carnitine, salts and derivatives thereof for reducing or preventing fatigue and improving cognitive function
10/11/2012WO2012136694A1 Pyridopyrazine derivatives and their use
10/11/2012WO2012136691A1 Pyridopyrazine derivatives and their use
10/11/2012WO2012136659A1 Sn-1(3) monoacylglycerides and lipid absorption
10/11/2012WO2012136655A1 Phenoxazinones or phenothiazones as inhibitors of amyloid formation
10/11/2012WO2012136622A1 Dihydropyrrolo pyrimidine derivatives as mtor inhibitors
10/11/2012WO2012136603A1 1,4-oxazepines as bace1 and/or bace2 inhibitors
10/11/2012WO2012136553A1 Substituted 2,3-dihydroimidazo[1,2-c]quinazoline salts
10/11/2012WO2012136549A1 Use of substituted 2,3-dihydroimidazo[1,2-c]quinazolines
10/11/2012WO2012136531A1 Substituted imidazopyridines and intermediates thereof
10/11/2012WO2012136504A1 Method for the preparation of process intermediates for the synthesis of argatroban monohydrate
10/11/2012WO2012136385A1 6,7-dihydro-[1,3,4]thiadiazolo-[3,2-a][1,3]diazepin derivative and pharmaceutical composition containing the same as neuromuscular blocker or skeletal muscle relaxant, and method for the preparation
10/11/2012WO2012136356A1 6,7-diydro-[1,3,4]thiadiazolo-[3,2-a][1,3]diazepin derivatives and pharmaceutical compositions containing the same as hypnotic or anesthetic agent and method for their preparation
10/11/2012WO2012136351A1 Tapentadol for treating pain associated with trigeminal neuralgia
10/11/2012WO2012136349A1 Tapentadol for preventing chronification of pain
10/11/2012WO2012136317A1 Rosmarinic acid for smoker dehabituation
10/11/2012WO2012136204A2 Preparation or dietary supplement
10/11/2012WO2012136147A1 Benzopyrone derivative and use thereof
10/11/2012WO2012136144A1 Camptothecin derivatives having anti-tumor activity
10/11/2012WO2012136133A1 Use of a-nor-5alpha-androstane compounds for preparing anti-malignant tumor medicine
10/11/2012WO2012136125A1 Compound dual-release capsule formulation comprised of bromodihydroartemisinin and a fe2+ agent
10/11/2012WO2012136121A1 Amino phenylpropanoid compound and use thereof for preparing immunosuppressant
10/11/2012WO2012136120A1 Aryl acrylamide compound and use thereof in preparing immunosuppressant
10/11/2012WO2012136111A1 Phenylpropionic acid compound, preparation method therefor and medicinal use thereof
10/11/2012WO2012136099A1 4-(substituted phenylamino)quinazoline derivative and preparation method therefor, pharmaceutical composition and use thereof
10/11/2012WO2012136080A1 Benzomorpholine derivatives, preparation method and use thereof
10/11/2012WO2012135970A1 Inhibitors of phosphatidic acid phosphohydrolase (pap), including d-propranolol and analogs thereof, alone or in combination with desipramine, for the treatment of cancers that depend on the epidermal growth factor receptor (egfr), oncogenic variants thereof and other members of the erbb/her family
10/11/2012WO2012135944A1 Protein kinase inhibitors
10/11/2012WO2012135937A1 Protein kinase inhibitors
10/11/2012WO2012125957A9 Methods and materials for reducing venous stenosis formation of an arteriovenous fistula or graft
10/11/2012WO2012111025A3 1,2,3-triazole containing artemisinin compounds and process for preparation thereof
10/11/2012WO2012111011A3 Low dosage combinations of fluoxetine and reboxetine for treating obesity
10/11/2012WO2012107498A4 Lysine demethylase inhibitors for myeloproliferative disorders
10/11/2012WO2012106118A3 Method of making ophthalmic devices and components thereof from hydrophobic acrylic (ha) polymers with reduced or eliminated glistenings
10/11/2012WO2012103457A3 Stilbene analogs and methods of treating cancer
10/11/2012WO2012103295A3 Small molecule rnase inhibitors and methods of use
10/11/2012WO2012101654A3 Novel triazine compounds
10/11/2012WO2012096929A3 Heteroaryl compounds and methods of use thereof
10/11/2012WO2012093091A3 New saccharide mimics and their use as inhibitors of angiogenesis and metastasis formation
10/11/2012WO2012092114A3 Oxidosqualene cyclase as a protein target for anticancer therapeutics
10/11/2012WO2012088425A9 Gap junction-enhancing agents for treatment of necrotizing enterocolitis and inflammatory bowel disease
10/11/2012WO2012085603A3 Dna sensors
10/11/2012WO2012085171A3 Pharmaceutical compositions of pyridinium and quinolinium derivatives
10/11/2012WO2012083306A3 Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators
10/11/2012WO2012083058A3 Anti-viral compounds
10/11/2012WO2012082765A3 Methods for decreasing body weight and treating diabetes
10/11/2012WO2012081944A3 Dental membrane and method of manufacturing the same
10/11/2012WO2012081907A3 Rna aptamer for e. coli o157:h7 strain
10/11/2012WO2012065065A9 Methods and compositions for modulating hair growth, wound healing and scar revision
10/11/2012WO2012061428A3 Nicotinamides as jak kinase modulators
10/11/2012WO2012025229A8 Composition and method of manufacture
10/11/2012WO2011156464A8 Crystalline forms of kinase inhibitors
10/11/2012WO2011131436A3 Cosmetic or dermatological preparations containing combinations of magnolia bark extract and acyl glutamates
10/11/2012WO2011119732A3 Method for integrin ligand discovery
10/11/2012WO2011117668A9 Carbazole linked pyrrolo[2,1-c][1,4]benzodiazepine hybrids as potential anticancer agents and process for the preparation thereof
10/11/2012US20120260358 Aptamer capable of binding to viral hemorrhagic septicemia virus
10/11/2012US20120259413 Devices, compositions and methods utilizing ep4 and ep2 receptor agonists for preventing, reducing or treating capsular contracture
10/11/2012US20120259187 Dynamic colorectal pdt application
10/11/2012US20120259152 Treatment of hypoxic tumors with localized oxygenation
10/11/2012US20120259151 Pyridopyrazine derivatives and their use
10/11/2012US20120259093 Expression of secreted human alpha-fetoprotein in transgenic animals
10/11/2012US20120259020 Transdermal therapeutic systems containing 4-n-butylresorcinol
10/11/2012US20120259018 Composition of dexibuprofen transdermal hydrogel
10/11/2012US20120259016 Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
10/11/2012US20120259015 Medicament for prophylactic and/or therapeutic treatment of hepatic steatosis or non-alcoholic steatohepatitis
10/11/2012US20120259014 Topical retnoid solutions
10/11/2012US20120259013 Liquid dosage forms of isotretinoin
10/11/2012US20120259012 Treatment for Amyotrophic Lateral Sclerosis
1 ... 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 ... 7860